UPDATE: Goldman Sachs Upgrades Thoratec Corporation to CL-Buy, Raises PT
Posted on December 03, 2012 at 09:24 AM EST
In a report published Monday, Goldman Sachs Group upgraded its rating on Thoratec Corporation (NASDAQ: THOR ) to CL-Buy, and raised its price target from $46.00 to $48.00. Goldman Sachs noted, “We add shares of Thoratec (THOR) to the Americas Conviction Buy List with a $48 12-month price target, implying